Using total cell lysates from all patient GBM cell isolates of cluster 4, GBM-300 of cluster 1, and GBM isolates randomly assigned from clusters 2 and 3, we successfully validated the SOMAscan® results for protein candidates MDK, CKM, CD59, STAT1, STAT6, and FN1 by Western blot analysis run in duplicates with β-actin serving as loading control (Figure 4A,B). This evidence concerns the gene CD59 and glioblastoma.